MYC and small cell lung carcinoma: Alves RC et al. reported MYC amplification was associated with poor survival (4.67 weeks of patients with MYC amplification vs. 26.15 weeks of patients without MYC amplification, p = 0.02) in the untreated SCLC patients [22].